The 1980 report that inhaled formaldehyde induced nasal squamous cell carcinomas in rats had a significant societal impact and resulted in extensive research in the fields of rodent nasal pathology and human cancer risk assessment. This article presents an overview of the evolution of these events. It is concluded that the nasal passages of humans and rats are fundamentally identical biological target organs. Nevertheless, in the case of human health risk assessment, minor differences between these species may be critically important. Special attention should be paid to interspecies differences in nasal dosimetry and local metabolism; thus, chemical toxicity data derived from rats require careful interpretation when used for human risk assessments. In the case of formaldehyde, it is recommended that low-concentration (≤2 ppm airborne exposure) extrapolation, where no tissue damage is observed, be uncoupled from the responses at high concentrations (≥6 ppm), where epithelial degeneration, regenerative cell replication, and inflammation appear to be essential driving forces in formaldehyde carcinogenesis. The presence of treatment-related nasal lesions in rats following exposure to chemicals should always be treated as an indication of a potential human health risk, whether exposure is by the inhalation, oral, or dermal route.
American Conference of Governmental Industrial Hygienists (1995). 1995-1996Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. American Conference of Governmental Industrial Hygienists, Cincinnati, Ohio.
2.
Albert RE, Sellakumar AR, Laskin S., Kuschner M., Nelson N., and Snyder CA (1982). Gaseous formaldehyde and hydrogen chloride induction of nasal cancer in the rat. J. Natl. Cancer Inst. 68: 597-603.
3.
Appelman LM, Woutersen RA, Zwart A., Falke HE, and Feron VJ (1988). One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J. Appl. Toxicol. 8: 85-90.
4.
Barrow CS (ed) (1986). Toxicology of the Nasal Passages. Hemisphere Publishing Corporation , New York.
5.
Bermudez E., Chen Z., Gross EA, Walker CL, Recio L., Pluta L., and Morgan KT (1994). Characterization of cell lines from formaldehyde-induced nasal tumors in rats. Mol. Carcinog. 9: 193-199.
6.
Bogdanffy MS , Morgan PH, Morgan KT, and Starr TB (1986). Binding of formaldehyde to human and rat nasal mucus and bovine serum albumin . Toxicol. Lett. 38: 145-154.
7.
Boysen M., Downs AM, Rigatu JP, Torjussen W., Hogetveit AC, Andersen I., Berge SR, Solberg LA, Abeler VM, and Reith A. (1994). Rates of regression and progression of dysplastic lesions in the nasal mucosa in nickel workers: A Markov model approach. Sci, Total Environ. 148: 311-318.
8.
Brown HR, Monticello TM, Maronpot RR, Randall HW, Hotchkiss JR, and Morgan KT (1991). Proliferative and neoplastic lesions in the rodent nasal cavity. Toxicol. Pathol. 19: 358-372.
9.
Buckley LA, Jiang XZ, James RA, Morgan KT, and Barrow CS (1984). Respiratory tract lesions induced by sensory irritants at the RD50 concentration. Toxicol. Appl. Pharmacol. 74: 417-429.
10.
Butterworth BE (1996). Letter to editor. Cancer Res. 56: 4270-4272.
11.
Butterworth BE, Conolly RB, and Morgan KT (1995). A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments . Cancer Lett. 93: 129-146.
12.
Butterworth BE , Popp JA, Conolly RB, and Goldsworthy TL (1992). Chemically induced cell proliferation in carcinogenesis. In: Mechanisms of Carcinogenesis in Risk Identification, H Vainio, PN Magee, DB McGregor, and AJ McMichael (eds). International Agency for Research on Cancer, Lyon, France, pp. 279-305.
13.
Calderon-Garciduefias L., Osorno-Velazquez A., Bravo-Alvarez H., Delgado-Chavez R., and Barrios-Marquez R. (1992). Histopathologic changes of the nasal mucosa in southwest metropolitan Mexico City inhabitants. Am. J. Pathol . 140: 225-232.
14.
Casanova M. , Deyo DF, and Heck Hd'A (1989). Covalent binding of inhaled formaldehyde to DNA in the nasal mucosa of Fischer-344 rats: Analysis of formaldehyde and DNA by high-performance liquid chromatography and provisional pharmacokinetic interpretation. Fundam. Appl. Toxicol. 12: 397-417.
15.
Casanova M. and Heck Hd'A (1997). Metabolism of Formaldehyde . European Centre for Ecotoxicology and Toxicology of Chemicals, Technical Report (in preparation), Brussels , Belgium.
16.
Casanova M. , Heck Hd'A , and Janszen D. (1996). Comments on 'DNA-protein crosslinks, a biomarker of exposure to formaldehyde-in vitro and in vivo studies' by Shaham et al. Carcinogenesis17: 2097-2098.
17.
Casanova M. , Morgan KT, Gross EA, Moss OR, and Heck Hd'A (1994). DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. Fundam. Appl. Toxicol. 23: 525-536.
18.
Casanova M. , Morgan KT, Steinhagen WH, Everitt JI, Popp JA, and Heck Hd'A (1991). Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: Pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. Fundam. Appl. Toxicol. 17: 409-428.
19.
Casanova-Schmitz M., David RM, and Heck Hd'A (1984a). Oxidation of formaldehyde and acetaldehyde by NAD+-dependent dehydrogenases in rat nasal mucosal homogenates . Biochem. Pharmacol. 33: 1137-1142.
20.
Casanova-Schmitz M. and Heck Hd'A (1983). Effects of formaldehyde exposure on the extractability of DNA from proteins in the rat nasal mucosa . Toxicol. Appl. Pharmacol. 70: 121-132.
21.
Casanova-Schmitz M., Starr TB, and Heck Hd'A (1984b). Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [H3]formaldehyde . Toxicol. Appl. Pharmacol. 76: 26-44.
22.
Chang JCF , Gross EA, Swenberg JA, and Barrow CS (1983). Nasal cavity deposition, histopathology, and cell proliferation after single or repeated formaldehyde exposures in B6C3F1 mice and F-344 rats. Toxicol. Appl. Pharmacol . 68: 161-176.
23.
Cohen SM and Ellwein LB (1990). Cell proliferation in carcinogenesis. Science249: 1007-1011.
24.
Cohen-Hubal EAC , Fedkiw PS, and Kimbell JS (1996a). Mass-transport models to predict toxicity of inhaled gases in the upper respiratory tract. J. Appl. Physiol. 80: 1415-1427.
25.
Cohen-Hubel EA, Kimbell JS, and Fedkiw PS (1996b). Incorporation of nasal-lining mass-transfer resistance into a CFD model for prediction of ozone dosimetry in the upper respiratory tract. Inhal. Toxicol. 8: 831-857.
26.
Cohen-Hubel EA , Schlosser PM, Conolly RB, and Kimbell JS (1997). Comparison of inhaled formaldehyde dosimetry predictions with DNA-protein cross-link measurements in the rat upper respiratory tract. Toxicol. Appl. Pharmacol . 143: 47-55.
27.
Collins JJ, Acquavella JF, and Esmen NA (1996). Formaldehyde exposure and upper respiratory cancer: An updated review and meta-analysis. Submitted.
28.
Conolly RB and Anderson ME (1993). An approach to mechanism-based cancer risk assessment for formaldehyde. Environ. Health Perspect. 101(suppl6): 169-176.
29.
Conolly RB, Andjelkovich DA, Casanova M., Heck Hd'A , Janszen DB, Kimbell JS, Morgan KT, and Recio L. (1995). Multidisciplinary, iterative examination of the mechanism of formaldehyde carcinogenicity: The basis for better risk assessment . CIIT Activities15: 1-11.
30.
Conolly RB, Morgan KT, Andersen ME, Monticello TM, and Clewell HJ (1992). A biologically-based risk assessment strategy for inhaled formaldehyde. Comments Toxicol. 4: 269-293.
31.
Coulston F. (1993). Editorial. Qual. Ass. Good Pract. Law2: 211-212.
32.
Consumer Product Safety Commission (1982). Ban of urea-formaldehyde foam insulation, withdrawal of proposed information labeling rule, and denial of petition to issue a standard . Fed. Regist. 47(64): 14366.
33.
Dahl AR and Hadley WH (1991). Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. Crit. Rev. Toxicol. 21: 345-372.
34.
Dasgupta A. , Guenard P., Anderson SM, Karsnitz JS, Ultman JS, and Morgan KT (1995). Calibration of a photographic method for imaging mass transfer in aqueous solutions. Int. J. Heat Mass Transfer38: 2029-2037.
35.
DeSesso JM (1993). The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways. Qual. Ass. Good Pract. Law2: 213-231.
36.
Eccles R. (1995). Rhinitis as a mechanism of respiratory defense . Eur. Arch. Otorhinolaryngol. 252(suppl1): S2-S7.
37.
Eccles R., Bende M., and Widdicombe JG (1987). Nasal blood vessels. In: Allergic and Vasomotor Rhinitis: Pathophysiological Aspects, 1sted., N Mygind and U Pipkorn (eds). Munksgaard, Copenhagen, Denmark, pp. 63-76.
38.
Farber E. (1995). Cell proliferation as a major risk factor for cancer: A concept of doubtful validity. Cancer Res. 55: 3759-3762.
39.
Farber E. (1996). Reply to letter to editor. Cancer Res. 56: 4272-4274.
40.
Feron VJ and Bosland MC (eds) (1989). Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk. Proceedings of the TNO-CIVO/NYU Nose Symposium, October 24-28, 1988, in Pudoc, Wageningen, Veldhoven, Netherlands.
41.
Feron VJ, Bruyntjes RA, Wouterson HR, Immel HR, and Appelman LM (1988). Nasal tumours in rats after short-term exposure to a cytotoxic concentration of formaldehyde. Cancer Lett . 39: 101-111.
42.
Feron VJ, Til HP, de Vrijer F., Woutersen RA, Cassee FR, and van Bladeren PJ (1991). Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment. Mut. Res. 259: 363-385.
43.
Feron VJ and Woutersen RA (1989). Role of tissue damage in nasal carcinogenesis . In: Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk, VJ Feron and MC Bosland (eds). Pudoc, Wageningen, Veldhoven, Netherlands, pp. 76-84.
44.
Frederick CB , Morris JB, Kimbell JS, Morgan KT, Hanna LM, and Scherer PW (1994). Comparison of four biologically-based dosimetry models for the rodent nasal cavity to describe the deposition and distribution of rapidly metabolized vapors. Inhal. Toxicol . 6: 135-157.
45.
Gallo MA and Doull J. (1996). History and scope of toxicology. In: Casarett and Doull's Toxicology, The Basic Science of Poisons, 5th ed., MO Amdur, J Doull, and CD Klaasen (eds). Pergamon Press, New York , pp. 3-11.
46.
Goldsworthy TL, Morgan KT, Popp JA, and Butterworth BE (1991). Guidelines for measuring chemically-induced cell proliferation in specific rodent target organs. In: Chemically-Induced Cell Proliferation: Implications for Risk Assessment, BE Butterworth and TJ Slaga (eds). Wiley, New York, pp. 253-284.
47.
Harkema JR (1991). Comparative aspects of nasal airway anatomy: Relevance to inhalation toxicology. Toxicol. Pathol. 19: 321-336.
48.
Harkema JR, Lee JK, Morgan KT, and Frederick CB (1997). Olfactory epithelial injury in monkeys after acute inhalation exposure to acrylic monomers. The Toxicologist36: 113. (abstract 576).
49.
Harkema JR and Morgan KT (1996). Normal morphology of the nasal passages in laboratory rodents. In: Monographs on Pathology of Laboratory Animals, Respiratory System, TC Jones, DL Dungworth, and U Mohr (eds). Springer-Verlag, New York, pp. 3-17.
50.
Hatch GE (1992). Comparative biochemistry of airway lining fluid . In: Treatise on Pulmonary Toxicology, Comparative Biology of the Normal Lung, Vol. 3, R. Parent (ed). CRC Press, Boca Raton, Louisiana, pp. 617-632.
51.
Hayashi S., Kikuta A., Ohtsuka A., and Masuda Y. (1991). Microvascular architecture of rat nasal associated lymphoid tissue. Arch. Histol. Cytol. 54: 279-287.
52.
Heck Hd'A (1997). Aldehydes. In: Comprehensive Toxicology, Toxicology of the Respiratory Tract, IG Sipes, AJ Gandolfi, and CA McQueen (eds). Elsevier Science, New York (in press).
53.
Heck Hd'A , Casanova M., and Starr TB (1990). Formaldehyde toxicity-New understanding. Crit. Rev. Toxicol . 20: 397-426.
54.
Heck Hd'A , Casanova-Schmitz M., Dodd PB, Schachter EN, Witek TJ, and Tosun T. (1985). Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am. Ind. Hyg. Assoc. J. 46: 1-3.
55.
Hernandez O. , Rhomberg L., Hogan K., Siegel-Scott C., Lai D., Grindstaff G., Henry M., and Cotruvo JA (1994). Risk assessment of formaldehyde . J. Hazard. Mater. 39: 161-172.
56.
Holmström M. , Rynnel-Dagoo B., and Wilhelmsson B. (1989). Antibody production in rats after long-term exposure to formaldehyde . Toxicol. Appl. Pharmacol. 100: 328-333.
57.
Internal Agency for Research on Cancer (1995). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 62, Wood Dust and Formaldehyde. World Health Organization, Geneva, Switzerland.
58.
Ibanes JD, Leininger JR, Jarabek AM, Harkema JR, Hotchkiss JA, and Morgan KT (1996). Reexamination of respiratory tract responses in rats, mice and rhesus monkeys chronically exposed to inhaled chlorine. Inhal. Toxicol. 8: 859-876.
59.
Jarabek AM (1994). Inhalation RfC methodology: Dosimetric adjustments and dose-response estimation of noncancer toxicity in the URT. Inhal. Toxicol. 6: 301-325.
60.
Keller DA, Heck Hd'A, Randall HW, and Morgan KT (1990). Histochemical localization of formaldehyde dehydrogenase in the rat. Toxicol. Appl. Pharmacol. 106: 311-326.
61.
Kepler GM, Joyner DR, Fleishman A., Richardson R., Gross EA, Morgan KT, and Kimbell JS (1995). Method for obtaining accurate geometrical coordinates of nasal airways for computer dosimetry modeling and lesion mapping. Inhal. Toxicol. 7: 1207-1224.
62.
Kepler GM, Richardson RR, Morgan KT, and Kimbell JS (1997). Computer simulation of nasal airflow in a rhesus monkey. Submitted.
63.
Kerns WD (1985). Polypoid adenoma of the nasal cavity in the laboratory rat. In: Monographs of Pathology of Laboratory Animals, Respiratory System, TC Jones, U Mohr, RD Hunt (eds). Springer-Verlag, New York, pp. 41-47.
64.
Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, and Swenberg JA (1983). Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43: 4382-4398.
65.
Keyhani K., Scherer PW, and Mozell MM (1995). Numerical sim
